Advertisement
Advertisement

PMN

PMN logo

ProMIS Neurosciences Inc. Common Shares (ON)

10.16
USD
Sponsored
+0.11
+1.09%
Jun 16, 15:59 UTC -4
Closed
exchange

After-Market

10.35

+0.19
+1.82%

PMN Earnings Reports

Positive Surprise Ratio

PMN beat 7 of 11 last estimates.

64%

Next Report

Date of Next Report
Aug 11, 2026
Estimate for Q2 26 (Revenue/ EPS)
--
/
-$1.62
Implied change from Q1 26 (Revenue/ EPS)
--
/
+28.57%
Implied change from Q2 25 (Revenue/ EPS)
--
/
-77.66%

ProMIS Neurosciences Inc. Common Shares (ON) earnings per share and revenue

On May 12, 2026, PMN reported earnings of -1.26 USD per share (EPS) for Q1 26, beating the estimate of -1.49 USD, resulting in a 15.52% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -1.78% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 3 analysts forecast an EPS of -1.62 USD, with revenue projected to reach -- USD, implying an increase of 28.57% EPS, and increase of 0.00% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Greenwich LifeSciences, Inc.
Report Date
Jun 04, 2026 For Q1 26
Estimate
-$0.33
Actual
-$0.39
Surprise
-15.86%
logo
Vistagen Therapeutics, Inc. Common Stock
Report Date
Jun 15, 2026 For Q4 26
Estimate
-$0.34
Actual
-$0.37
Surprise
-7.75%
FAQ
For Q1 2026, ProMIS Neurosciences Inc. Common Shares (ON) reported EPS of -$1.26, beating estimates by 15.52%, and revenue of $0.00, 0% as expectations.
The stock price moved down -1.78%, changed from $10.68 before the earnings release to $10.49 the day after.
The next earning report is scheduled for Aug 11, 2026.
Based on 3 analysts, ProMIS Neurosciences Inc. Common Shares (ON) is expected to report EPS of -$1.62 and revenue of -- for Q2 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement